Clinical Trial Update: A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 dose-volume study of a treatment for elevated intraocular pressure in open-angle glaucoma or ocular hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: TERMINATED